Emergence of Candida auris : An International Call to Arms
2016; Oxford University Press; Volume: 64; Issue: 2 Linguagem: Inglês
10.1093/cid/ciw696
ISSN1537-6591
AutoresCornelius J. Clancy, M. Hong Nguyen,
Tópico(s)Antifungal resistance and susceptibility
ResumoOn June 24, 2016, the Centers for Disease Control and Prevention (CDC) issued an extraordinary alert, advising US healthcare facilities "to be on the lookout for Candida auris in patients" [1].The alert noted that C. auris infections had been identified in several countries since 2009.Although cases have not been described in the United States, CDC reported that a C. auris isolate from 2013 was detected during ongoing surveillance.Within a week, Public Health England (PHE) announced that C. auris was recovered from healthcare facilities in that country, and 1 hospital has been managing an outbreak involving more than 40 patients in an intensive care unit (ICU) since April 2015 [2].The outbreak persisted despite regular patient screening, environmental decontamination, ward closure, and other enhanced infection control interventions [2].In this issue of Clinical Infectious Diseases, Lockhart and colleagues describe the study that prompted the CDC alert [3].Reports of C. auris infections have been published from Japan, South Korea, India, South Africa, Kuwait, and Venezuela, describing 45 patients with candidemia
Referência(s)